Liquidia Corp’s recently made public that its General Counsel Schundler Russell unloaded Company’s shares for reported $0.11 million on Jul 14 ’25. In the deal valued at $14.28 per share,7,836 shares were sold. As a result of this transaction, Schundler Russell now holds 577,977 shares worth roughly $8.73 million.
Then, Saggar Rajeev sold 5,327 shares, generating $76,070 in total proceeds. Upon selling the shares at $14.28, the Chief Medical Officer now owns 271,413 shares.
Before that, Moomaw Scott sold 4,797 shares. Liquidia Corp shares valued at $68,501 were divested by the Chief Commercial Officer at a price of $14.28 per share. As a result of the transaction, Moomaw Scott now holds 223,231 shares, worth roughly $3.37 million.
Oppenheimer downgraded its Liquidia Corp [LQDA] rating to an Underperform from a a Perform in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid December with a ‘”an Overweight”‘ rating. Scotiabank began covering LQDA with “Sector outperform” recommendation on October 16, 2024. Raymond James revised its rating on August 19, 2024. It rated LQDA as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of LQDA
On Monday, Liquidia Corp [NASDAQ:LQDA] saw its stock jump 3.85% to $15.1. Over the last five days, the stock has gained 4.28%. Liquidia Corp shares have risen nearly 33.22% since the year began. Nevertheless, the stocks have risen 28.40% over the past one year.
How much short interest is there in Liquidia Corp?
A steep rise in short interest was recorded in Liquidia Corp stocks on 2025-06-13, growing by 6.0 million shares to a total of 19.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 13.5 million shares. There was a rise of 30.79%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 16, 2024 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $27 price target.
